AGORA INC-ADR (API)

US00851L1035 - ADR

6.35  +1.61 (+33.97%)

After market: 6.27 -0.08 (-1.26%)

Fundamental Rating

3

API gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 279 industry peers in the Software industry. The financial health of API is average, but there are quite some concerns on its profitability. API is quite expensive at the moment. It does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year API has reported negative net income.
API had a negative operating cash flow in the past year.
API had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: API reported negative operating cash flow in multiple years.

1.2 Ratios

Looking at the Return On Assets, with a value of -6.45%, API is in line with its industry, outperforming 45.52% of the companies in the same industry.
With a Return On Equity value of -7.47%, API perfoms like the industry average, outperforming 51.97% of the companies in the same industry.
Industry RankSector Rank
ROA -6.45%
ROE -7.47%
ROIC N/A
ROA(3y)-11.88%
ROA(5y)-23.19%
ROE(3y)-13.1%
ROE(5y)-25.93%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

API has a Gross Margin (62.58%) which is comparable to the rest of the industry.
In the last couple of years the Gross Margin of API has declined.
The Profit Margin and Operating Margin are not available for API so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 62.58%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.76%
GM growth 5Y-2.28%

5

2. Health

2.1 Basic Checks

API does not have a ROIC to compare to the WACC, probably because it is not profitable.
API has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, API has more shares outstanding
The debt/assets ratio for API is higher compared to a year ago.

2.2 Solvency

API has an Altman-Z score of 3.44. This indicates that API is financially healthy and has little risk of bankruptcy at the moment.
With a Altman-Z score value of 3.44, API perfoms like the industry average, outperforming 53.41% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that API is not too dependend on debt financing.
API has a Debt to Equity ratio of 0.04. This is comparable to the rest of the industry: API outperforms 58.06% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 3.44
ROIC/WACCN/A
WACC10.05%

2.3 Liquidity

A Current Ratio of 8.29 indicates that API has no problem at all paying its short term obligations.
API's Current ratio of 8.29 is amongst the best of the industry. API outperforms 94.62% of its industry peers.
A Quick Ratio of 8.29 indicates that API has no problem at all paying its short term obligations.
The Quick ratio of API (8.29) is better than 94.98% of its industry peers.
Industry RankSector Rank
Current Ratio 8.29
Quick Ratio 8.29

5

3. Growth

3.1 Past

API shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 35.62%, which is quite impressive.
The Revenue for API has decreased by -11.92% in the past year. This is quite bad
The Revenue has been growing by 26.50% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)35.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-13.04%
Revenue 1Y (TTM)-11.92%
Revenue growth 3Y1.94%
Revenue growth 5Y26.5%
Sales Q2Q%-9.84%

3.2 Future

The Earnings Per Share is expected to grow by 24.53% on average over the next years. This is a very strong growth
The Revenue is expected to grow by 9.42% on average over the next years. This is quite good.
EPS Next Y52.26%
EPS Next 2Y35.26%
EPS Next 3Y24.53%
EPS Next 5YN/A
Revenue Next Year-1.09%
Revenue Next 2Y3.4%
Revenue Next 3Y9.34%
Revenue Next 5Y9.42%

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for API. In the last year negative earnings were reported.
Also next year API is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

A more expensive valuation may be justified as API's earnings are expected to grow with 24.53% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y35.26%
EPS Next 3Y24.53%

0

5. Dividend

5.1 Amount

No dividends for API!.
Industry RankSector Rank
Dividend Yield N/A

AGORA INC-ADR

NASDAQ:API (11/27/2024, 9:25:19 PM)

After market: 6.27 -0.08 (-1.26%)

6.35

+1.61 (+33.97%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap579.64M
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -6.45%
ROE -7.47%
ROCE
ROIC
ROICexc
ROICexgc
OM N/A
PM (TTM) N/A
GM 62.58%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 8.29
Quick Ratio 8.29
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
High Growth Momentum
Growth
EPS 1Y (TTM)35.62%
EPS 3YN/A
EPS 5Y
EPS Q2Q%
EPS Next Y52.26%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-11.92%
Revenue growth 3Y1.94%
Revenue growth 5Y
Sales Q2Q%
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y